Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Biotechnology
Big data presents an array of opportunities for the pharmaceutical industry, but companies must be careful who they partner with, said Myra McCormack, associate patent counsel at Johnson & Johnson, yesterday.   26 September 2018
Americas
‘Evergreening’, ‘delinking’ and a UN report on access to medicines were all up for debate yesterday, during a panel session at the 2018 AIPPI World Congress in Cancún, Mexico.   26 September 2018
Americas
The inter partes review process has had a huge impact on biosimilar litigation, but it isn’t truly fulfilling its goal of being an alternative to district court litigation.   26 September 2018
Americas
DLA Piper has added two partners from Hogan Lovells to its IP and technology practice in New York.   25 September 2018
Big Pharma
The World Intellectual Property Organization and the International Federation of Pharmaceutical Manufacturers & Associations today launched an online tool designed to provide information on medical patents.   25 September 2018
Big Pharma
The EU General Court today rejected a trademark appeal brought by Swiss pharmaceutical company Novartis.   25 September 2018
Americas
The UK government has today confirmed that a “winter fact-finding mission” will soon be carried out by UK life sciences experts in Texas, building on the science and technology cooperation agreement signed by the UK and the US last year.   24 September 2018
Americas
US-based Allergan and the Saint Regis Mohawk Tribe have accused pharmaceutical company Amneal of infringing two patents in its generic version of an eye treatment.   24 September 2018
Americas
American biotech 3Scan is combining robotics with machine learning and automation to offer microscopy services for the 3D analysis of cells, tissues, and organs. LSIPR met general counsel Nada Rastad to hear about some of the patenting challenges.   24 September 2018
Asia-Pacific
The Australian Competition & Consumer Commission announced yesterday that it has approved the merger of generic drugs companies Arrow and Apotex.   21 September 2018